Skip to main content
C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
1.540
+0.040 (2.67%)
May 8, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Targeted Protein Degradation
20.76M
Log In
Log In
Log In
Log In
Upgrade
Targeted Protein Degradation Growth
-33.25%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
United States
20.76M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-33.25%
Log In
Log In
Log In
Log In
Upgrade